Skip to content

About Us
Product Pipeline
Marketed Products

News

Contact Us

Stay up to date with our latest research
and corporate developments

Latest News & Media

News

2017/6/5

TaiRx presents CVM-1118 Phase I Clinical Trial Progress at ASCO

TaiRx, Inc. (6580) publishes its Phase I clinical trial result in the United States and Taiwan on CV…
[Read More]
2016/6/18

Science reported TaiRx’s CVM-1118 as the first drug entering clinical trial, inhibiting the formation of vasculogenic mimicry in cancer.

This issue of Science magazine (June 17, 2016) featured a column on how malignant tumor cells avoid …
[Read More]
2016/3/28

TaiRx’s oral cancer drug with a promising forecast.

View full coverage
[Read More]
2016/3/18

23 major pharmaceutical companies attended the cross-strait new drug discussion panel.

View full coverage
[Read More]

←Previous Page

1 … 3 4 5 6 7

Facebook
Link
YouTube
Instagram

Copyright© 2026 TaiRx, inc.